Stress Relief Supplements Market Summary
As per Market Research Future Analysis, the Global Stress Relief Supplements Market was valued at USD 0.5 Billion in 2023 and is projected to reach USD 0.9001 Billion by 2032, growing at a CAGR of 6.75% from 2024 to 2032. The market is driven by increasing consumer awareness of stress management benefits and a rise in stress-related health issues. The North American region is expected to dominate the market due to a focus on preventive healthcare and an aging population. Key segments include ashwagandha in sources, capsules & tablets in forms, and conventional in categories, with store-based distribution channels leading sales.
Key Market Trends & Highlights
The market is witnessing significant trends driven by health consciousness and product innovation.
- Market Size in 2023: USD 0.5 Billion
- Projected Market Size by 2032: USD 0.9001 Billion
- CAGR from 2024 to 2032: 6.75%
- Dominant Source Segment: Ashwagandha
Market Size & Forecast
2023 Market Size | USD 0.5 Billion |
2032 Market Size | USD 0.9001 Billion |
CAGR (2024-2032) | 6.75% |
Major Players
Key players include ADM (US), PharmalineaLid (Slovenia), Virtue Vitamins LIC (US), NaturesPlus (US), The Himalaya Drug Company (India), Plant Therapy Essential Oil (US), Cureveda (India), Naturalite Asia Co. Ltd. (Korea), Ricola (Switzerland), and Nutraceutical International Corporation.